AmeriCann Q1 FY23 Revenue Grows 13% YoY, What About Adjusted EBITDA? -…

AmeriCann Q1 FY23 Revenue Grows 13% YoY, What About Adjusted EBITDA? -…

Facebook
Twitter
LinkedIn

AmeriCann Inc. A CAN released insightful financial and operating results for the quarter ended December 2022 Earnings of $734.766an increase of 13% compared to $650,945 for the quarter ended December 2021.

Financially Highlights for the quarter ending December 2022

  • Annual gross margins were 98.1%.

  • Adjusted EBITDA for the quarter increased $111,794 to $337,623, an increase of 49.5% compared to the same quarter last year.

  • Net income of $22,745 compared to a net loss of $533,028 for the quarter ended December 2021.

“AmeriCann’s focus on financial performance has delivered outstanding results with four consecutive quarters of positive net income,” said the CEO Tim Keogh. “We look forward to building on these results for the future as we expand operations at our Massachusetts Cannabis Center to generate even greater cash flow.”

AmeriCann is in the final design stages of expanding its MCC development in Freetown, Massachusetts. The Company has secured provisional cultivation and manufacturing licenses for MCC. The next phase of the Massachusetts Cannabis Center will require up to 60,000 square feet of extraction, manufacturing and distribution infrastructure and approximately 160,000 square feet of additional cannabis cultivation infrastructure.

The Benzinga Cannabis Capital Conference is back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is where DEALS are CLOSED, money raised, M&A started and companies meet investors and important partners. Join us April 11-12 at the Fontainebleau Miami Beach Hotel in Florida. Don’t miss it. Get your tickets now. Prices will rise very soon.

Photo of Richard T At Unsplash

[ad_2]

Source story

More to explorer